Latham & Watkins Advises Enko Chem in its US$45 Million Series B Financing

Enko Chem, Inc. has publicly launched after securing US$45 million in a Series B round of financing, bringing its total funding raised to date to US$66 million. Led by the Bill & Melinda Gates Foundation, the latest round attracted a strong mix of existing (Anterra Capital and Rabobank) and new (Finistere Ventures, Novalis LifeSciences, Germin8 Ventures, TO Ventures Food) investors.

Latham & Watkins LLP represented Enko Chem, Inc. in the financing with a Boston-based corporate team led by partner Kristen Grannis, with associates Spencer Ricks, Peter Prial, and Tyler Mills.